XTX Topco Ltd Takes Position in Addus HomeCare Corporation (NASDAQ:ADUS)

Key Points

• XTX Topco Ltd has acquired 8,128 shares of Addus HomeCare Corporation, worth approximately $804,000, indicating growing interest from institutional investors.
• Several analysts have upgraded their ratings on Addus HomeCare, with a consensus rating of "Buy" and a price target of $142.57.
• Addus HomeCare reported a 20.3% increase in revenue year-over-year, with a net margin of 6.52% and earnings per share of $1.42 for the last quarter.

XTX Topco Ltd bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 8,128 shares of the company's stock, valued at approximately $804,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Natixis increased its stake in Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after purchasing an additional 132 shares in the last quarter. Bailard Inc. acquired a new position in Addus HomeCare in the 1st quarter valued at approximately $208,000. Heritage Family Offices LLP raised its position in Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after purchasing an additional 143 shares during the last quarter. Private Advisor Group LLC lifted its holdings in Addus HomeCare by 52.4% during the first quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after acquiring an additional 875 shares in the last quarter. Finally, Hohimer Wealth Management LLC boosted its position in Addus HomeCare by 6.3% during the first quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after purchasing an additional 152 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Analyst Ratings Changes

A number of research firms have issued reports on ADUS. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. TD Cowen increased their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday. Macquarie restated an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. Finally, JMP Securities reiterated a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $142.86.

Insider Activity at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Trading Down 3.7%

Shares of Addus HomeCare stock traded down $4.30 during trading on Thursday, reaching $110.65. 338,023 shares of the company were exchanged, compared to its average volume of 192,854. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The firm has a market capitalization of $2.04 billion, a price-to-earnings ratio of 24.78, a P/E/G ratio of 1.65 and a beta of 0.80. The business has a 50-day moving average price of $111.85 and a 200-day moving average price of $108.37.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. During the same quarter last year, the firm earned $1.35 EPS. The firm's revenue for the quarter was up 21.8% compared to the same quarter last year. Sell-side analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.